Rafugen DBM Gel Pro

Rafugen DBM Gel Pro

Other

Information

Rafugen™ DBM is US FDA 501k approved and used in various indications such as spinal fusion, implantation, dental, and trauma. Being both osteoinductive and osteoconductive, it contains high-content of demineralized bone for optimal interbody fusion. CMC high viscosity gel allows excellent moldability while maintaining a good shape. Allograft cortical powder and cortical-cancellous powder are predictive of excellent prognosis for bone fusion and are also used as bone void filler. It is available in both syringe and vial types with varying particle sizes to meet users’ needs.
Cellumed Co., LtdCellumed, a certified tissue bank, acquired US FDA mark in its strenuous effort on the research of bone graft substitutes, and also developed a complete set of world’s one and only titanium-based Total Knee Replacement system. Furthermore, a protein-based CHO-cell growth factor (rhBMP2) was launched first in Asia and second in the world exploring more potential in the bone fusion market. Products are distributed globally and customized in different form factors to meet the needs of patients and surgeons. Moreover, Cellumed is open to collaboration with partners worldwide to further expand the clinical horizon.